v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash Flows From Operating Activities:    
Net earnings/(loss) $ 3,775 $ (10,224)
Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:    
Depreciation and amortization, net 2,023 5,128
Deferred income taxes (214) (1,042)
Stock-based compensation 281 258
Impairment charges 318 871
Divestiture gains and royalties (585) (550)
Acquired IPRD 1,695 13,081
Equity investment (gains)/losses, net 100 (209)
Contingent consideration fair value adjustments 336 0
Other adjustments (2) 20
Changes in operating assets and liabilities:    
Receivables (469) (540)
Inventories (165) (443)
Accounts payable (72) 41
Rebates and discounts 254 70
Income taxes payable (567) (1,033)
Other (837) (268)
Net cash provided by operating activities 5,871 5,160
Cash Flows From Investing Activities:    
Sale and maturities of marketable debt securities 744 822
Purchase of marketable debt securities (1,257) (358)
Proceeds from sales of equity investments 12 60
Capital expenditures (621) (546)
Divestiture and other proceeds 513 511
Acquisition and other payments, net of cash acquired (363) (21,426)
Net cash used in investing activities (972) (20,937)
Cash Flows From Financing Activities:    
Proceeds from issuance of short-term debt obligations 0 2,987
Repayments of short-term debt obligations 0 (2,731)
Other short-term financing obligations, net 426 409
Proceeds from issuance of long-term debt 0 12,883
Repayments of long-term debt (643) (395)
Dividends (2,520) (2,429)
Stock option proceeds and other, net (92) (103)
Net cash (used in)/provided by financing activities (2,829) 10,621
Effect of exchange rates on cash, cash equivalents and restricted cash 194 (67)
Increase/(decrease) in cash, cash equivalents and restricted cash 2,264 (5,223)
Cash, cash equivalents and restricted cash at beginning of period 10,347 11,519
Cash, cash equivalents and restricted cash at end of period $ 12,611 $ 6,296